var data={"title":"Sodium chloride preparations (saline and oral salt tablets): Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Sodium chloride preparations (saline and oral salt tablets): Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6963?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information\" class=\"drug drug_general\">see &quot;Sodium chloride preparations (saline and oral salt tablets): Drug information&quot;</a> and <a href=\"topic.htm?path=sodium-chloride-preparations-saline-and-oral-salt-tablets-patient-drug-information\" class=\"drug drug_patient\">see &quot;Sodium chloride preparations (saline and oral salt tablets): Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221678\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>4-Way Saline [OTC];</li>\n      <li>Afrin Saline Nasal Mist [OTC];</li>\n      <li>Allclenz [OTC] [DSC];</li>\n      <li>Altachlore [OTC];</li>\n      <li>Altamist Spray [OTC];</li>\n      <li>Atrapro Dermal Spray;</li>\n      <li>Ayr Nasal Mist Allergy/Sinus [OTC];</li>\n      <li>Ayr Saline Nasal Drops [OTC];</li>\n      <li>Ayr Saline Nasal Gel [OTC];</li>\n      <li>Ayr Saline Nasal Neti Rinse [OTC];</li>\n      <li>Ayr Saline Nasal No-Drip [OTC];</li>\n      <li>AYR Saline Nasal Rinse [OTC];</li>\n      <li>Ayr Saline Nasal [OTC];</li>\n      <li>Ayr [OTC];</li>\n      <li>Baby Ayr Saline [OTC];</li>\n      <li>Broncho Saline [OTC];</li>\n      <li>Deep Sea Nasal Spray [OTC];</li>\n      <li>DiaB Klenz [OTC];</li>\n      <li>Elta Dermal Wound Cleanser [OTC];</li>\n      <li>Entsol Nasal Wash [OTC] [DSC];</li>\n      <li>Entsol Nasal [OTC];</li>\n      <li>Entsol [OTC] [DSC];</li>\n      <li>Humist [OTC] [DSC];</li>\n      <li>HyperSal;</li>\n      <li>MicroKlenz Wound Cleanser [OTC];</li>\n      <li>Muro 128 [OTC];</li>\n      <li>Na-Zone [OTC] [DSC];</li>\n      <li>Nasal Moist [OTC];</li>\n      <li>Nebusal;</li>\n      <li>Ocean Complete Sinus Rinse [OTC];</li>\n      <li>Ocean for Kids [OTC];</li>\n      <li>Ocean Nasal Spray [OTC];</li>\n      <li>Ocean Ultra Saline Mist [OTC];</li>\n      <li>Pretz Irrigation [OTC];</li>\n      <li>Pretz [OTC];</li>\n      <li>PulmoSal;</li>\n      <li>RadiaKlenz [OTC];</li>\n      <li>Remedy 4-in-1 Body Cleanser [OTC];</li>\n      <li>Rhinaris [OTC];</li>\n      <li>Safe Wash [OTC];</li>\n      <li>Saline Flush ZR;</li>\n      <li>Saline Mist Spray [OTC];</li>\n      <li>Saljet Rinse [OTC];</li>\n      <li>Saljet [OTC];</li>\n      <li>Sea Soft Nasal Mist [OTC] [DSC];</li>\n      <li>Sea-Clens Wound Cleanser [OTC];</li>\n      <li>Sochlor [OTC];</li>\n      <li>Sodium Chloride Thermoject Sys [DSC];</li>\n      <li>SwabFlush Saline Flush;</li>\n      <li>Ultra-Klenz [OTC];</li>\n      <li>Wound Wash Saline [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062201\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Electrolyte Supplement, Oral</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Electrolyte Supplement, Parenteral</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Lubricant, Ocular</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Sodium Salt</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11445045\" class=\"block don drugH1Div\"><span class=\"drugH1\">Dosing: Neonatal</span>\n    <p style=\"text-indent:0em;display:inline\">Dosage depends upon clinical condition, fluid, electrolyte, and acid-base balance of patient.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Normal daily requirement: </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Premature neonates: Oral, IV: 2 to 5 mEq/kg/day (Mirtallo 2004); infants born at &le;32 weeks gestation may require higher dosage (up to 8 mEq/kg/day) for the first 2 weeks of life (Al-Dahhan 2002) </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Term neonates: Oral, IV: 2 to 5 mEq/kg/day (Mirtallo 2004) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Hyponatremia: </b> IV: <b>0.9% isotonic solution:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dose (mEq sodium) = [desired serum sodium (mEq/L) &ndash; actual serum sodium (mEq/L)] x 0.6 x wt (kg) </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Note:</b> For acute correction, use 125 mEq/L as the &ldquo;desired serum sodium&rdquo;; acutely correct serum sodium by 5 mEq/L/dose increments (eg, from a serum concentration of 120 mEq/L to 125 mEq/L) using a serum correction rate of &lt;0.4 to 0.5 mEq/L/hour; goal serum correction rate: &le;8 to 10 mEq/L/day. Hypertonic saline should be used with caution and only for severe cases of hyponatremia with a serum sodium &lt;120 mEq/L and patient experiencing symptoms (Marcialis 2011).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Nasal dryness/congestion: Note:</b> Consult product specific labeling for approved use in neonates; Intranasal: <b>Intranasal solution:</b> 2 to 6 drops per nostril as needed; product concentrations vary; most are a 0.65% to 0.9% solution</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Ocular  dryness:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ophthalmic, ointment: Apply once daily or more often as needed </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ophthalmic solution: Instill 1 to 2 drops into affected eye(s) every 3 to 4 hours  </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Volume expansion, resuscitation: </b> AHA, AAP: Neonatal resuscitation recommendation: IV: <b>0.9% isotonic solution:</b> 10 mL/kg; may repeat (Kattwinkel 2010); in a retrospective analysis of neonates requiring CPR at birth, 21 &plusmn; 14 mL/kg was the effective dose (n=13, GA: &ge;34 weeks) (Wyckoff 2005) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062196\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information\" class=\"drug drug_general\">see &quot;Sodium chloride preparations (saline and oral salt tablets): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">Dosage depends upon clinical condition, fluid, electrolyte, and acid-base balance of patient; systemic hypertonic solutions (&gt;0.9%) should only be used for the initial treatment of acute serious symptomatic hyponatremia or increased intracranial pressure.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Normal daily requirements: </b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants and Children &le;50 kg: Oral, IV: 2 to 5 mEq/kg/day (Mirtallo 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &gt;50 kg and Adolescents: Oral, IV: 1 to 2 mEq/kg/day (Mirtallo 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Bronchiolitis, viral (inpatient):</b> Infants and Children 1 to 24 months: Inhalation: <b>3% solution</b>: 4 mL inhaled every 2 hours for 3 doses followed by every 4 hours for 5 doses and continued every 6 hours until discharge (Kuzik 2007); pretreatment with a bronchodilator may be necessary to prevent potential bronchospasm </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Bronchodilator diluent:</b> Infants, Children, and Adolescents: Inhalation: 1 to 3 sprays (1 to 3 mL) to dilute bronchodilator solution in nebulizer before administration </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Cystic fibrosis:</b> Children &ge;6 years and Adolescents: Inhalation:<b> 7% solution</b>: 4 mL inhaled twice daily. <b>Note:</b> Clinically, some CF centers use 3% or 3.5% inhaled solutions if patients cannot tolerate 7%; pretreatment with a bronchodilator is recommended to prevent potential bronchospasm </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Dehydration:</b> Infants, Children, and Adolescents: IV: <b>0.9% isotonic solution:</b>  Initial:  20 mL/kg/dose; maximum dose: 1,000 mL followed by remaining replacement using sodium chloride concentration appropriate for age over 24 hours for dehydration (Meyers 2009) </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Hyponatremia:</b> Infants, Children, and Adolescents: IV: <b>Note:</b> Use <b>0.9% isotonic solution or 3% hypertonic solution</b> depending on clinical severity and etiology.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Dose (mEq sodium) = [desired serum sodium (mEq/L) - actual serum sodium (mEq/L)] x 0.6 x wt (kg)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <b>Note:</b> For acute correction, use 125 mEq/L as the &quot;desired serum sodium&quot;; acutely correct serum sodium by 5 mEq/L/dose increments (eg, from a serum concentration of 120 mEq/L to 125 mEq/L) using a serum correction rate of &le;2 mEq/L/hour for the first few hours followed by a serum correction rate of &le;0.5 mEq/L/hour; goal serum correction rate: &le;12 mEq/L/day; more gradual correction in increments of 10 mEq/L/day is indicated in the asymptomatic patient </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Hypovolemic shock:</b> Infants, Children, and Adolescents: IV: <b>0.9% isotonic solution:</b>  20 mL/kg/dose; may repeat up to &ge;60 mL/kg until capillary perfusion improves or signs of fluid overload occur (Ceneviva, 1998; Parker 2004) </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Increased intracranial pressure (ICP):</b> Infants, Children, and Adolescents: IV:  <b>3% hypertonic solution:</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Bolus: Limited data available; dosing regimens variable:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Traumatic brain injury guidelines: 6.5 to 10 mL/kg/dose (Fisher 1992; Kochanek 2012)</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Alternate dosing: 5 mL/kg/dose administered early in presentation (during critical care transport) was reported in a retrospective trial of 101 pediatric patients (age range: 2 months to 17 years) with suspected increased ICP (Luu 2011); some centers use 2 to 5 mL/kg/dose; boluses are typically infused over 30 minutes but are occasionally administered more rapidly depending on the clinical scenario (Abd-Allah 2012; Brenkert 2013; Kamat 2003)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Continuous IV infusion: 0.1 to 1 mL/kg/hour titrated to maintain ICP &lt;20 mm Hg (Kochanek 2012); monitor serum sodium concentration closely; some centers utilize titration protocols with rate adjustments varying with serum sodium concentration; maintain serum osmolarity &lt;360 mOsmol/L</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Nasal dryness/congestion:</b>  <b>Note:</b> Consult product specific labeling for approved use in pediatric patients; available concentrations vary.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants: Intranasal: <b>Intranasal solution:</b> 2 to 6 drops per nostril as needed</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children and Adolescents: Intranasal: <b>Intranasal solution:</b> Use as often as needed </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Ocular dryness:</b> Infants, Children, and Adolescents: </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Ophthalmic, ointment: Apply once daily or more often as needed </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Ophthalmic, solution: Instill 1 to 2 drops into affected eye(s) every 3 to 4 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Bronchodilator diluent:</b> Inhalation: 1 to 3 sprays (1 to 3 mL) to dilute bronchodilator solution in nebulizer before administration</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Chloride maintenance electrolyte requirement in parenteral nutrition:</b> IV: As needed to maintain acid-base balance with parenteral nutrition; use equal amounts of chloride and acetate to maintain balance and adjust ratio based on individual patient needs (Mirtallo 2004)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>GU irrigant:</b> Irrigation: 1 to 3 L/day by intermittent irrigation</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Hyponatremia:</b> IV: To correct acute (&lt;24 hours) or chronic (&gt;48 hours), severe (&lt;120 mEq/L) hyponatremia: In general, a serum sodium concentration increase of 4 to 6 mEq/L within a 24-hour period is sufficient to improve most symptoms of hyponatremia. In chronic severe hyponatremia, overcorrection risks iatrogenic osmotic demyelination syndrome. For patients with severe symptoms or other need for urgent correction, one approach is to increase serum sodium concentration by 4 to 6 mEq/L within the first 6 hours and postpone any further correction until the next day at a correction rate of 4 to 6 mEq/L per day. Choice of sodium correction fluid concentration is dependent upon the severity of the hyponatremia with more concentrated solutions (eg, 3% NaCl) for more severe cases; monitor serum sodium closely during administration (Sterns 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Irrigation:</b> Spray affected area</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Nasal congestion:</b> Intranasal: 2 to 3 sprays in each nostril as needed</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Ophthalmic:</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Ointment: Apply once daily or more often</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Solution: Instill 1 to 2 drops into affected eye(s) every 3 to 4 hours</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Replacement:</b> IV: Determined by laboratory determinations mEq</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Sodium maintenance electrolyte requirement in parenteral nutrition:</b> IV: 1 to 2 mEq/kg/24 hours; customize amounts based on individual patient needs (Mirtallo 2004).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2016668\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Aerosol Solution, Inhalation: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Broncho Saline: 0.9% (90 mL [DSC], 240 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Aerosol Solution, Nasal [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ocean Complete Sinus Rinse:  (177 mL) [drug free]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, Nasal: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ayr Saline Nasal:  (14.1 g) [contains aloe barbadensis, brilliant blue fcf (fd&amp;c blue #1), methylparaben, propylparaben, soybean oil]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ayr Saline Nasal No-Drip:  (22 mL) [contains aloe barbadensis, benzalkonium chloride, benzyl alcohol, soybean oil]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Rhinaris: 0.2% (28.4 g [DSC]) [contains benzalkonium chloride, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Liquid, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Allclenz:  (360 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Atrapro Dermal Spray:  (236 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">DiaB Klenz:  (240 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Elta Dermal Wound Cleanser:  (240 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">MicroKlenz Wound Cleanser:  (240 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">RadiaKlenz:  (240 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Remedy 4-in-1 Body Cleanser: 0.5% (236 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sea-Clens Wound Cleanser:  (178 mL, 355 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ultra-Klenz:  (240 mL, 360 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Nebulization Solution, Inhalation: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.9% (3 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Nebulization Solution, Inhalation [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">HyperSal: 3.5% (4 mL) [latex free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">HyperSal: 7% (4 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Nebusal: 3% (4 mL); 6% (4 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">PulmoSal: 7% (4 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.9% (3 mL, 5 mL, 15 mL); 3% (4 mL, 15 mL); 7% (4 mL); 10% (4 mL, 15 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ointment, Ophthalmic: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Altachlore: 5% (3.5 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Muro 128: 5% (3.5 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 5% (3.5 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Packet, Nasal [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ayr Saline Nasal Neti Rinse: Sodium chloride and sodium bicarbonate (40 ea) [iodine free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">AYR Saline Nasal Rinse: Sodium chloride and sodium bicarbonate (50 ea, 51 ea, 100 ea) [iodine free]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Saljet: 0.9% (30 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Wound Wash Saline: 0.9% (210 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Safe Wash: 0.9% (210 mL) [drug free, latex free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Saljet Rinse: 0.9% (30 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sodium Chloride Thermoject Sys: 0.9% (10 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.9% (2 mL, 5 mL [DSC], 10 mL, 20 mL, 30 mL, 100 mL); 14.6% (20 mL, 40 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.9% (1 mL [DSC], 2 mL, 2.5 mL [DSC], 3 mL, 5 mL, 10 mL, 20 mL, 50 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Intravenous: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">SwabFlush Saline Flush: 0.9% (10 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.45% (25 mL, 50 mL, 100 mL, 250 mL, 500 mL, 1000 mL); 0.9% (2.5 mL [DSC], 3 mL [DSC], 10 mL, 25 mL, 50 mL, 100 mL, 150 mL, 250 mL, 500 mL, 1000 mL); 3% (500 mL); 5% (500 mL); 23.4% (30 mL, 100 mL, 200 mL, 250 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Intravenous [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Saline Flush ZR: 0.9% (2.5 mL, 5 mL, 10 mL) [latex free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.9% (1 mL, 2 mL, 2.5 mL, 3 mL, 5 mL, 10 mL, 50 mL, 100 mL, 125 mL, 250 mL, 500 mL, 1000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Irrigation: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.9% (250 mL, 500 mL, 1000 mL, 1500 mL, 2000 mL, 3000 mL, 4000 mL, 5000 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Nasal: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4-Way Saline:  (29.6 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Afrin Saline Nasal Mist: 0.65% (30 mL, 45 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Altamist Spray: 0.65% (45 mL, 60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ayr: 0.65% (50 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ayr Nasal Mist Allergy/Sinus: 2.65% (50 mL) [contains benzalkonium chloride]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ayr Saline Nasal Drops: 0.65% (50 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Baby Ayr Saline: 0.65% (30 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Deep Sea Nasal Spray: 0.65% (44 mL) [contains benzalkonium chloride]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Entsol:  (30 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Humist: 0.65% (45 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Na-Zone: 0.65% (59 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Nasal Moist: 0.65% (15 mL, 45 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ocean for Kids: 0.65% (37.5 mL) [alcohol free, drug free; contains benzalkonium chloride]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ocean for Kids: 0.65% (37.5 mL) [drug free; contains benzalkonium chloride]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ocean Nasal Spray: 0.65% (45 mL, 66 mL, 104 mL, 480 mL) [contains benzalkonium chloride]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Pretz:  (50 mL, 946 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Pretz Irrigation:  (237 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Rhinaris: 0.2% (30 mL) [contains benzalkonium chloride, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Saline Mist Spray: 0.65% (44 mL) [contains benzalkonium chloride]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sea Soft Nasal Mist: 0.65% (45 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 0.65% (44 mL, 45 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Nasal [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Entsol Nasal: 3% (100 mL) [drug free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Entsol Nasal Wash:  (237 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ocean Ultra Saline Mist:  (90 mL) [drug free]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Ophthalmic: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Altachlore: 5% (15 mL, 30 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Muro 128: 2% (15 mL); 5% (15 mL, 30 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Sochlor: 5% (15 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 5% (15 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 4 mEq/mL (23.4%) (473 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Swab, Nasal: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ayr Saline Nasal Gel:  (20 ea) [contains methylparaben, propylparaben, soybean oil, trolamine (triethanolamine)]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1 g</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221650\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F21963631\" class=\"block dosfc drugH1Div\"><span class=\"drugH1\">Dosage Forms Considerations</span><p>(For additional information <a href=\"topic.htm?path=sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information\" class=\"drug drug_general\">see &quot;Sodium chloride preparations (saline and oral salt tablets): Drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">1 g sodium chloride = elemental sodium 393.3 mg = 17.1 mEq sodium = sodium 17.1 mmol</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062205\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Inhalation: Nebulization; studies administering hypertonic saline utilized varying types of nebulizers, including jet and ultrasonic</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Nasal: Spray into 1 nostril while gently occluding other </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Ophthalmic: Apply to affected eye(s); avoid contact of bottle tip with eye or skin </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Oral: Administer with full glass of water </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Parenteral: Central-line administration is preferred for hypertonic saline (&gt;0.9%) if available and/or if infusion is to be continued; peripheral administration may be necessary for initiation of treatment in critical patients; use of peripheral administration should be limited; intraosseous administration may be used if unable to obtain intravenous access (Luu 2011)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Rate of administration:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Bolus:</p>\n    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">\n      <b>0.9% isotonic solution:</b></p>\n    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">Hypotension, shock:</p>\n    <p style=\"text-indent:-2em;margin-left:12em;text-align:justify;\">Neonates: Published data not available; consider slower administration to avoid IVH (Kattwinkel 2010)</p>\n    <p style=\"text-indent:-2em;margin-left:12em;text-align:justify;\">Infants, Children, and Adolescents: Administer boluses over 5 minutes (Brierley 2009) </p>\n    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">Dehydration: Bolus: Administer over 20 to 60 minutes</p>\n    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">\n      <b>3% hypertonic solution:</b> In pediatric patients, boluses are typically infused over 30 minutes (Abd-Allah 2012; Kamat 2003). Although data is limited, faster rates have been reported; in a retrospective trial (n=56), a median infusion time of 17 minutes (IQR: 10 to 30 minutes) was reported for a median dose of 4.1 mL/kg. In this same trial, a subset (n=15) received bolus doses over &le;10 minutes; four of these patients received 3 to 5 mL/kg over ~3 minutes in the emergency department (Brenkert 2013)    </p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Continuous IV infusion: Maximum rate: 1 mEq/kg/hour</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Vesicant at higher concentrations (&gt;1%); ensure proper needle or catheter placement prior to and during infusion; avoid extravasation. If extravasation occurs, stop infusion immediately and disconnect (leave cannula/needle in place); gently aspirate extravasated solution (do <b>NOT</b> flush the line); remove needle/cannula; elevate extremity. Apply dry warm compresses (Hastings-Tolsma 1993). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3149019\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store injection at room temperature; do not freeze. Protect from heat. Use only clear solutions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062204\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Restoration of sodium ion in hyponatremia (FDA approved in pediatric patients [age not specified] and adults), restores moisture to nasal membranes (OTC products: FDA approved in pediatric patients [age not specified] and adults; approved ages for generic products may vary; consult labeling for specific information), source of electrolytes and water for expansion of the extracellular fluid compartment (FDA approved in pediatric patients [age not specified] and adults), diluent and delivery system of compatible drug additives (FDA approved in pediatric patients [age not specified] and adults); has also been used for reduction of intracranial pressure (ICP), improvement of mucociliary clearance and airway hydration in CF and acute viral bronchiolitis, reduction of corneal edema, and prevention of muscle cramps and heat prostration</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221696\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Afrin (saline) may be confused with Afrin (oxymetazoline)</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">High alert medication:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">The Institute for Safe Medication Practices (ISMP) includes this medication (IV formulation &gt;0.9% concentration) among its list of drugs which have a heightened risk of causing significant patient harm when used in error.</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Other safety concerns:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Per The Joint Commission (TJC) recommendations, concentrated electrolyte solutions (eg, NaCl &gt;0.9%) should not be available in patient care areas.</p>\n        <p style=\"text-indent:-2em;margin-left:4em;margin-top:2em;text-align:justify;\">Inappropriate use of low sodium or sodium-free intravenous fluids (eg, D<sub>5</sub>W, hypotonic saline) in pediatric patients can lead to significant morbidity and mortality due to hyponatremia (ISMP, 2009).</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221693\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cardiovascular: Cardiac failure, hypotension (transient; especially with adult administration of 23.4% NaCl), localized phlebitis, thrombosis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Osmotic demyelination syndrome (due to rapid correction of hyponatremia)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Electrolyte disturbance (dilution of electrolytes), hypernatremia, hypervolemia, hypokalemia, water intoxication</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Nausea, vomiting (oral administration)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Respiratory: Bronchospasm (inhalation with hypertonic solutions), pulmonary edema</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221671\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to sodium chloride or any component of the formulation; hypertonic uterus, hypernatremia, fluid retention</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221654\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Extravasation: Concentrated solutions of sodium chloride (&gt;1%) are vesicants; ensure proper needle or catheter placement prior to and during infusion. Avoid extravasation.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hemolysis: The use of hypotonic saline solutions (eg, sodium chloride 0.225%) may result in hemolysis if administered rapidly and for prolonged periods. If hypotonic saline solutions become necessary, administration as D5W/NaCl 0.2% or NaCl 0.45% is recommended for most patients (eg, those without hyperglycemia).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hyponatremia: Administration of low sodium or sodium-free IV solutions may result in significant hyponatremia or water intoxication; monitor serum sodium concentration closely. In the treatment of acute hypernatremia (ie, development over a couple of hours), serum sodium concentration should be corrected no faster than 1 to 2 mEq/L per hour. If patient has been chronically hypernatremic, correct serum sodium no faster than 0.5 mEq/L per hour and by no more than 10 to 12 mEq/L in a given 24-hour period; use extreme caution since rapid correction may result in cerebral edema, herniation, coma, and death (Adrogue 2000; Kraft 2005).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sodium toxicity: Rate of correction is dependent upon whether or not hyponatremia is acute or chronic. Sodium toxicity (eg, osmotic demyelination syndrome [ODS]) is almost exclusively related to how fast a sodium deficit is corrected; both rate and magnitude are extremely important. For patients with acute (&lt;24 hours) or chronic (&gt;48 hours), severe (&lt;120 mEq/L) hyponatremia, a serum sodium concentration increase of 4 to 6 mEq/L within a 24-hour period is sufficient for most patients. In chronic severe hyponatremia, overcorrection risks iatrogenic ODS. For patients with severe symptoms or other need for urgent correction, may increase by 4 to 6 mEq/L within the first 6 hours and postpone any further correction until the next day at a correction rate of 4 to 6 mEq/L per day. Do not increase serum sodium by more than 8 mEq/L in any 24-hour period for patient at high risk for ODS. For patients at normal risk for ODS, do not increase serum sodium by more than 10 to 12 mEq/L in any 24-hour period or by more than 18 mEq/L in any 48-hour period (Verbalis 2013). Choice of sodium concentration is dependent upon the severity of the hyponatremia with more concentrated solutions (eg, NaCl 3%) for more severe cases; monitor serum sodium closely during administration (Sterns 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cirrhosis: Use with caution in patients with cirrhosis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Edema: Use with caution in patients with edema.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Heart failure: Use with caution in patients with heart failure.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypertension: Use with caution in patients with hypertension.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Renal impairment: Use with caution in patients with renal impairment; may cause sodium retention.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Bacteriostatic sodium chloride contains benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Irrigants: For external use only; not for parenteral use. Do not use during electrosurgical procedures. Irrigating fluids may be absorbed into systemic circulation; monitor for fluid or solute overload.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Wound Wash Saline: For single-patient use only.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25956038\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">In neonates, maximum serum concentration correction rate should generally not exceed 10 mEq/L/day; in infants, children, adolescents, and adults, do not exceed a maximum serum concentration correction rate of 12 mEq/L/day. Administration of low sodium or sodium free IV solutions may result in significant hyponatremia or water intoxication in pediatric patients; monitor serum sodium concentration.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures, and respiratory depression; use caution (AAP 1997; Shehab 2009). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300053\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221659\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12796&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Lithium: Sodium Chloride may increase the excretion of Lithium. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tolvaptan: Sodium Chloride may enhance the adverse/toxic effect of Tolvaptan. Specifically, Hypertonic Saline may increase the risk for too rapid of an increase in serum sodium concentrations.  Management: This interaction is specific to Hypertonic Saline.  Avoid concurrent use of Hypertonic Saline with Tolvaptan.<i> Risk X: Avoid combination</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221661\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13888258\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. Sodium requirements do not change during pregnancy (IOM 2004). Nasal saline rinses may be used for the treatment of pregnancy rhinitis (Wallace, 2008)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062200\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Serum sodium, chloride, I &amp; O, weight; ICP, serum osmolarity (when used to treat increased ICP), capillary perfusion, MAP, CVP (fluid resuscitation) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062203\" class=\"block rer drugH1Div\"><span class=\"drugH1\">Reference Range</span>\n    <p style=\"text-indent:0em;display:inline\">Serum/plasma sodium concentration: </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Premature neonates: 132 to 140 mEq/L </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Full-term neonates: 133 to 142 mEq/L </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Infants &ge;2 months to Adults: 135 to 145 mEq/L</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221653\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Principal extracellular cation; functions in fluid and electrolyte balance, osmotic pressure control, and water distribution</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221670\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Oral: Rapid </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Widely distributed </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Primarily urine; also sweat, tears, saliva</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1062209\" class=\"block adi drugH1Div\"><span class=\"drugH1\">Additional Information</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">IV solutions: NS (0.9%) = 154 mEq/L; 3% NaCl = 513 mEq/L; 5% NaCl = 856 mEq/L</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet 1 g = 17.1 mEq</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">3% NaCl: Osmolarity: 1027 mOsm/L</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F221673\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Aerosol solution</b> (Broncho Saline Inhalation)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (240 mL): $6.78</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Remedy 4-in-1 Body Cleanser External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.5% (236 mL): $7.05</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Nebulization</b> (HyperSal Inhalation)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3.5% (4 mL): $0.88</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7% (4 mL): $0.88</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Nebulization</b> (Nebusal Inhalation)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3% (4 mL): $0.76</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">6% (4 mL): $0.80</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Nebulization</b> (PulmoSal Inhalation)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7% (4 mL): $0.80</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Nebulization</b> (Sodium Chloride Inhalation)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (3 mL): $0.13</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3% (4 mL): $0.40</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">7% (4 mL): $0.30</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10% (4 mL): $0.40</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Altachlore Ophthalmic)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (3.5 g): $13.62</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Muro 128 Ophthalmic)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (3.5 g): $19.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Ointment</b> (Sodium Chloride (Hypertonic) Ophthalmic)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (3.5 g): $12.11</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Pack</b> (Ayr Saline Nasal Neti Rinse Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.57 g (40): $7.45</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Pack</b> (AYR Saline Nasal Rinse Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1.57 g (100): $7.74</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Afrin Saline Nasal Mist Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (30 mL): $2.66</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Altachlore Ophthalmic)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (15 mL): $17.34</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ayr Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (50 mL): $2.39</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ayr Nasal Mist Allergy/Sinus Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.65% (50 mL): $3.41</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ayr Saline Nasal Drops Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (50 mL): $2.39</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Baby Ayr Saline Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (30 mL): $2.39</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Entsol Nasal Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3% (100 mL): $32.62</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Muro 128 Ophthalmic)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (15 mL): $18.22</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (15 mL): $19.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Nasal Moist Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (15 mL): $2.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ocean for Kids Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (37.5 mL): $3.12</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ocean Nasal Spray Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (45 mL): $3.06</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Rhinaris Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.2% (30 mL): $10.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Safe Wash External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (210 mL): $6.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Saline Flush ZR Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (5 mL): $3.34</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Saline Nasal Spray Nasal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.65% (44 mL): $1.65</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Saljet External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (30 mL): $0.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Saljet Rinse External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (30 mL): $0.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sodium Chloride (Hypertonic) Ophthalmic)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (15 mL): $12.11</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sodium Chloride Flush Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (10 mL): $3.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sodium Chloride Injection)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (10 mL): $1.09</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.5 mEq/mL (40 mL): $1.62</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sodium Chloride Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.45% (250 mL): $3.77</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (100 mL): $5.96</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">3% (500 mL): $2.51</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4 mEq/mL (100 mL): $4.01</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5% (500 mL): $10.68</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sodium Chloride Irrigation)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (1000 mL): $5.17</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Sodium Chloride Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">4 mEq/mL (473 mL): $56.40</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (SwabFlush Saline Flush Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (10 mL): $1.26</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Wound Wash Saline External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.9% (210 mL): $5.00</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Sodium Chloride Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1 g (1000): $140.00</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2869407\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Ai Na Duo (CN);</li>\n      <li>Alive (BR);</li>\n      <li>Alrin Baby (IL);</li>\n      <li>Antiedema (ES);</li>\n      <li>Apisal (AE, QA, SA);</li>\n      <li>Aqua-Rinosol (RU);</li>\n      <li>Breathy (ID);</li>\n      <li>Chlorek Sodowy 24Na (PL);</li>\n      <li>Clean-AF (IL);</li>\n      <li>Descodrin (BR);</li>\n      <li>Droser (TR);</li>\n      <li>Earinse (HK);</li>\n      <li>FESS Nasal Gel (AU);</li>\n      <li>Fima NS (ID);</li>\n      <li>Fisiolimp (CL);</li>\n      <li>Fizyolen (TR);</li>\n      <li>Hidrathea (ES);</li>\n      <li>Hiperton (MX);</li>\n      <li>HO-SOL (UA);</li>\n      <li>Hydrabak (IT);</li>\n      <li>Hynasal (IN);</li>\n      <li>HyperSal 6 (AU);</li>\n      <li>Hypersalt (PH);</li>\n      <li>Hypersol (AR, BD, IN);</li>\n      <li>Hytosol (IN);</li>\n      <li>Infusol (MY);</li>\n      <li>Inj. natrii chlorati isotonica (PL);</li>\n      <li>Jellywash (FR);</li>\n      <li>Kochsalz (AT);</li>\n      <li>Larmabak (AR, FR, HK, SG, TR, VE);</li>\n      <li>Libenar (IT);</li>\n      <li>Maresis (BR);</li>\n      <li>Maxidrate (BR);</li>\n      <li>Miwana (PL);</li>\n      <li>Muco Clear (GB);</li>\n      <li>Muconase (PH);</li>\n      <li>Muro 128 (KR);</li>\n      <li>Naclin (AR);</li>\n      <li>Nafavine (VE);</li>\n      <li>Narium (AU, NZ);</li>\n      <li>Nasakid (CL);</li>\n      <li>Nasalt (IN);</li>\n      <li>Nasoclear (IN, PH);</li>\n      <li>Natriclo (BE);</li>\n      <li>Natrii chloridum (EE);</li>\n      <li>Natrii chloridum 0,9% solutio pro irrigatione (PL);</li>\n      <li>Natrium chloratum (PL);</li>\n      <li>Nazol Aqua (RU);</li>\n      <li>Nebusal (GB);</li>\n      <li>Neorino (BR);</li>\n      <li>No-Sol (UA);</li>\n      <li>Normaline (AE);</li>\n      <li>Normasol (SG);</li>\n      <li>Normlgel (FR);</li>\n      <li>Norsalin (QA);</li>\n      <li>Nosalen (UA);</li>\n      <li>Ocean Spray (IL);</li>\n      <li>Oftalook (AR);</li>\n      <li>Oftarinol (PL);</li>\n      <li>Olynth salin (DE);</li>\n      <li>Omni-Sorb (DE);</li>\n      <li>Ophth-hypertonic (PK);</li>\n      <li>Ophth-lubric (PK);</li>\n      <li>Osmogel (IN);</li>\n      <li>Otrisalin (TR);</li>\n      <li>Phylarm (MX);</li>\n      <li>Physiodose (HK, IT, MY, PL);</li>\n      <li>Physiologic (CH);</li>\n      <li>Physiologicasol (BE);</li>\n      <li>Physiorhine (BE);</li>\n      <li>Polyrinse (ZA);</li>\n      <li>Rinokid (CL);</li>\n      <li>Rinolyuks (UA);</li>\n      <li>Rinomist (QA);</li>\n      <li>Rinowash (IT);</li>\n      <li>Rizosin (RU);</li>\n      <li>Salacyn (SG);</li>\n      <li>Salimist (SA);</li>\n      <li>Salinor (BD);</li>\n      <li>Saloride (BD);</li>\n      <li>Salsol (HU);</li>\n      <li>Sensitive Eyes Saline Solution (PL);</li>\n      <li>Serophy (CH);</li>\n      <li>Sinus (CL);</li>\n      <li>Snif (BR, PH);</li>\n      <li>Sodisol (BD);</li>\n      <li>Sodium Chloride (PL);</li>\n      <li>Solnasin (PL);</li>\n      <li>Sterilear Ear &amp; Body Piercing Spray (AU);</li>\n      <li>Tipotaf (IL);</li>\n      <li>Totalatlas (AR);</li>\n      <li>Urgo sterile (DE);</li>\n      <li>Wida NS (ID);</li>\n      <li>Xenosol (BD);</li>\n      <li>Xylisol (AR)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Abd-Allah, S. Personal communication. February 2012. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/11487763 /pubmed\" target=\"_blank\" id=\"11487763 \">11487763 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Al-Dahhan J, Jannoun L, and Haycock GB, &quot;Effect of Salt Supplementation of Newborn Premature Infants on Neurodevelopmental Outcome at 10-13 Years of Age,&quot; <i>Arch Dis Child Fetal Neonatal Ed</i>, 2002, 86(2):F120-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/11882555/pubmed\" target=\"_blank\" id=\"11882555\">11882555</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Brenkert TE, Estrada CM, McMorrow SP, Abramo TJ. Intravenous hypertonic saline use in the pediatric emergency department. <i>Pediatr Emerg Care</i>. 2013;29(1):71-73.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/23283268 /pubmed\" target=\"_blank\" id=\"23283268 \">23283268 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Brierley J, Carcillo JA, Choong K, et al, &quot;Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: 2007 Update From the American College of Critical Care Medicine,&quot; <i>Crit Care Med</i>, 2009, 37(2):666-88. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/19325359/pubmed\" target=\"_blank\" id=\"19325359\">19325359</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ceneviva G, Paschall JA, Maffei F, et al, &quot;Hemodynamic Support in Fluid-Refractory Pediatric Septic Shock,&quot; <i>Pediatrics</i>, 1998, 102(2):e19.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/9685464/pubmed\" target=\"_blank\" id=\"9685464\">9685464</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol - United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. Available at <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/6810084 /pubmed\" target=\"_blank\" id=\"6810084 \">6810084 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dellon EP, Donaldson SH, Johnson R, et al, &quot;Safety and Tolerability of Inhaled Hypertonic Saline in Young Children With Cystic Fibrosis,&quot; <i>Pediatr Pulmonol</i>, 2008, 43(11):1100-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/18828160/pubmed\" target=\"_blank\" id=\"18828160\">18828160</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Elkins MR, Robinson M, Rose BR, et al, &quot;A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients With Cystic Fibrosis,&quot; <i>N Engl J Med</i>, 2006, 354(3):229-40.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/16421364/pubmed\" target=\"_blank\" id=\"16421364\">16421364</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Fisher B, Thomas D, and Peterson B, &quot;Hypertonic Saline Lowers Raised Intracranial Pressure in Children After Head Trauma,&quot; <i>J Neurosurg Anesthesiol</i>, 1992, 4(1):4-10.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/15815431/pubmed\" target=\"_blank\" id=\"15815431\">15815431</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hastings-Tolsma MT, Yucha CB, Tompkins J, Robson L, Szeverenyi N. Effect of warm and cold applications on the resolution of I.V. infiltrations.<i> Res Nurs Health</i>. 1993;16(3):171-178.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/8497669/pubmed\" target=\"_blank\" id=\"8497669\">8497669</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Institute for Safe Medication Practice, &ldquo;Plain D<sub>5</sub>W or Hypotonic Saline Solutions Post-Op Could Result in Acute Hyponatremia and Death in Healthy Children,&rdquo; ISMP Medication Safety Alert, August 13, 2009. Available online at http://www.ismp.org/Newsletters/acutecare/articles/20090813.asp. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine), <i>Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate</i>, Washington, DC: National Academy Press, 2004.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kamat P, Vats A, Gross M, et al. Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis.<i> Pediatr Crit Care Med</i>. 2003;4(2):239-242.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/12749659/pubmed\" target=\"_blank\" id=\"12749659\">12749659</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kattwinkel J, Perlman JM, Aziz K, et al, &quot;Part 15: Neonatal Resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,&quot; <i>Circulation</i>, 2010, 122(18 Suppl 3):909-19.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/20956231/pubmed\" target=\"_blank\" id=\"20956231\">20956231</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Khanna S, Davis D, Peterson B, et al, &quot;Use of Hypertonic Saline in the Treatment of Severe Refractory Posttraumatic Intracranial Hypertension in Pediatric Traumatic Brain Injury,&quot; <i>Crit Care Med</i>, 2000, 28(4):1144-51.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/10809296/pubmed\" target=\"_blank\" id=\"10809296\">10809296</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kochanek PM, Carney N, Adelson PD, et al, &quot;Guidelines for the Acute Medical Management of Severe Traumatic Brain Injury in Infants, Children, and Adolescents - Second Edition,&quot; <i>Pediatr Crit Care Med</i>, 2012, 139(Suppl 10):1-82.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/22217782/pubmed\" target=\"_blank\" id=\"22217782\">22217782</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kuzik BA, Al-Qadhi SA, Kent S, et al, &quot;Nebulized Hypertonic Saline in the Treatment of Viral Bronchiolitis in Infants,&quot; <i>J Pediatr</i>, 2007, 151(3):266-70, 270.e1.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/17719935/pubmed\" target=\"_blank\" id=\"17719935\">17719935</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Luu JL, Wendtland CL, Gross MF, et al, &quot;Three-Percent Saline Administration During Pediatric Critical Care Transport,&quot; <i>Pediatr Emerg Care</i>, 2011, 27(12):1113-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/22134236/pubmed\" target=\"_blank\" id=\"22134236\">22134236</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Marcialis MA, Dessi A, Pintus MC, et al, &quot;Neonatal Hyponatremia: Differential Diagnosis and Treatment,&quot; <i>J Matern Fetal Neonatal Med</i>, 2011, 24(Suppl 1):75-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/21942597/pubmed\" target=\"_blank\" id=\"21942597\">21942597</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Meyers R, &quot;Pediatric Fluid and Electrolyte Therapy,&rdquo; <i>J Pediatr Pharmacol Ther</i>, 2009, 14:204&ndash;11</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mirtallo J, Canada T, Johnson D, et al, &quot;Safe Practices for Parenteral Nutrition,&quot; <i>JPEN J Parenter Enteral Nutr</i>, 2004, 28(6):39-70.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/15568296/pubmed\" target=\"_blank\" id=\"15568296\">15568296</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Parker MM, Hazelzet JA, and Carcillo JA, &quot;Pediatric Considerations,&quot; <i>Crit Care Med</i>, 2004, 32(11 Suppl):S591-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/15542968/pubmed\" target=\"_blank\" id=\"15542968\">15542968</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sterns RH, Hix JK, Silver SM. Management of hyponatremia in the ICU. <i>Chest</i>. 2013;144(2):672-679.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/23918113/pubmed\" target=\"_blank\" id=\"23918113\">23918113</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Subbarao P, Balkovec S, Solomon M, et al, &quot;Pilot Study of Safety and Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis,&quot; <i>Pediatr Pulmonol</i>, 2007, 42(5):471-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/17436328/pubmed\" target=\"_blank\" id=\"17436328\">17436328</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wallace DV, Dykewicz MS, Bernstein DI, et al, &quot;The Diagnosis and Management of Rhinitis: An Updated Practice Parameter,&quot; <i>J Allergy Clin Immunol</i>, 2008, 122(2 Suppl):1-84.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/1866258/pubmed\" target=\"_blank\" id=\"1866258\">1866258</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wyckoff MH, Perlman JM, and Laptook AR, &quot;Use of Volume Expansion During Delivery Room Resuscitation in Near-Term and Term Infants,&quot; <i>Pediatrics</i>, 2005, 115(4):950-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-chloride-preparations-saline-and-oral-salt-tablets-pediatric-drug-information/abstract-text/15805369/pubmed\" target=\"_blank\" id=\"15805369\">15805369</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12796 Version 220.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F221678\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1062201\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Neonatal\" href=\"#F11445045\" class=\"outlineLink\">Dosing: Neonatal</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1062196\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F2016668\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F221650\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms Considerations\" href=\"#F21963631\" class=\"outlineLink\">Dosage Forms Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1062205\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F3149019\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1062204\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F221696\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F221693\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F221671\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F221654\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F25956038\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300053\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F221659\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F221661\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13888258\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1062200\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Reference Range\" href=\"#F1062203\" class=\"outlineLink\">Reference Range</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F221653\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F221670\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Additional Information\" href=\"#F1062209\" class=\"outlineLink\">Additional Information</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F221673\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F2869407\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12796|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=sodium-chloride-preparations-saline-and-oral-salt-tablets-drug-information\" class=\"drug drug_general\">Sodium chloride preparations (saline and oral salt tablets): Drug information</a></li><li><a href=\"topic.htm?path=sodium-chloride-preparations-saline-and-oral-salt-tablets-patient-drug-information\" class=\"drug drug_patient\">Sodium chloride preparations (saline and oral salt tablets): Patient drug information</a></li></ul></div></div>","javascript":null}